. Author manuscript; available in PMC: 2017 Jan 1.

Published in final edited form as: J Gastrointest Surg. 2015 Sep 24;20(1):165–171. doi: 10.1007/s11605-015-2948-3

Table 3.

Adequate Staging

	Percent of patients adequately stage (≥16 lymph nodes)	P Value

Male	98/119 (82%)	0.43
Female	88/103 (85%)

Age<60 years	72/83 (87%)	0.29
Age≥60 years	113/139 (81%)

BMI<30 kg/m²	145/169 (86%)	0.03
BMI≥30 kg/m²	39/53 (74%)

Neoadjuvant chemotherapy	99/111 (89%)	0.02
No Neoadjuvant chemotherapy	85/111 (77%)

Total/Subtotal Gastrectomy	76/88 (86%)	0.33
Distal Gastrectomy	109/134 (81%)

D1 Lymphadenectomy	10/16 (63%)	0.03
D2 Lymphadenectomy	175/206 (85%)

No EVD	80/111 (72%)	<0.0001
EVD	105/111 (95%)

BMI: body mass index; EVD: ex vivo dissection